SCHEMBL6707629

SCHEMBL6707629

O=C(Nc1ccc(Cl)cc1-c1noc(=O)[nH]1)c1cc2cccc(NC(=O)c3ccc(F)cc3F)c2[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.45
TP53 P04637 2/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
PLA2G7 Q13093 4/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
GRIK1 P39086 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PLCG2 P16885 1/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
THRB P10828 1/20 0.38
LMNA P02545 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
AURKA O14965 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710264 0.90 POLB (0.45) RXFP1TP53POLBMAPTPLA2G7
SCHEMBL6713656 0.89 GRIK1 (0.42) RXFP1TP53POLBMAPTPLA2G7
SCHEMBL6710411 0.88 PKM (0.45) RXFP1TP53POLBMAPTPLA2G7
SCHEMBL6712036 0.86 KCNMA1 (0.45) PLA2G7GRIK1MEN1KMT2APLCG2
SCHEMBL6710325 0.86 RXFP1 (0.40) RXFP1TP53POLBMAPTPLA2G7
SCHEMBL6710141 0.86 GRIK1 (0.44) RXFP1PLA2G7GRIK1PLCG2
SCHEMBL6709173 0.86 GRIK1 (0.44) TP53POLBMAPTPLA2G7GRIK1
SCHEMBL6707881 0.85 PARP14 (0.42) RXFP1TP53POLBMAPTPLA2G7
SCHEMBL6712543 0.85 GRIK1 (0.43) RXFP1TP53POLBMAPTPLA2G7
SCHEMBL6708655 0.85 NHERF1 (0.46) RXFP1GRIK1MEN1KMT2APLCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 RXFP1 3836/4885TP53 2699/4885POLB 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.